Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025

Core Insights - Neurocrine Biosciences, Inc. will present new data from the Phase 2 SAVITRI study of osavampator for adults with major depressive disorder at Psych Congress 2025 [1] Group 1 - The SAVITRI study's top-line results were initially announced in April 2024 [1] - The poster presentation has been selected as a finalist for the Psych Congress Poster Awards [1] - The event will take place from September 17-21, 2025, in San Diego [1]